Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|January 14, 2004
The Hermansky-Pudlak syndrome 3 (cocoa) protein is a component of the biogenesis of lysosome-related organelles complex-2 (BLOC-2)Rashi Gautam, Sreenivasulu Chintala, Wei Li, et al.
Scientific Reports|January 8, 2022
ECG monitoring of post-stroke occurring arrhythmias: an observational study using 7-day Holter ECGClaudia Carrarini, V Di Stefano, M Russo, et al.
European Journal of Clinical Nutrition|April 18, 2003
Waist circumference as a predictor of cardiovascular and metabolic risk factors in obese girlsC Maffeis, N Corciulo, C Livieri, et al.
Molecular Human Reproduction|September 21, 2016
Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndromeL Scotti, M Di Pietro, N Pascuali, et al.
International Journal of Immunopathology and Pharmacology|June 13, 2008
No evidence of involvement of Chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reactionR Sessa, I Santino, M Di Pietro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 18, 2015
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER CohortM C Postorino, M Prosperi, E Quiros-Roldan, et al.
The Journal of Biological Chemistry|August 25, 2023
Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytesAlexandra Unapanta, Farbod Shavarebi, Jacob Porath, et al.
HIV Medicine|June 13, 2002
Adherence to HIV treatment: results from a 1-year follow-up studyM Martini, S D'Elia, F Paoletti, et al.
Biochemistry|May 21, 2003
Specific antibody-DNA interaction: a novel strategy for tight DNA recognitionSantiago M Di Pietro, Juan M Centeno, M Laura Cerutti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN studyS Nozza, L Galli, A Antinori, et al.
Pageof 12